Inno Clinical Outcomes LLC entered the industry of Research Institute in 2013 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541712, which describes it as a Research Institute. For further clarification, the SIC classifies this business under the code 8733 and described it as a Research Institute. The business provides service to the B2B market.
To acquire more information, please contact Kathryn Bradrick by calling (919) 274-1901 during business hours. You can also write to the business’ Single Location at 5309 Highgate Drive, Durham, North Carolina NC 27713. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Inno Clinical Outcomes LLC |
| Representative: | Kathryn Bradrick |
| Place of Business: | 5309 Highgate Drive, Durham, NC 27713 |
| Contact Number: | (919) 274-1901 |
| Type of Service: | Research Institute |
| SIC Number: | 8733 |
| NAICS Number: | 541712 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2013 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Inno Clinical Outcomes LLC is a company operating from Durham, North Carolina providing professional Research Institute and relevant B2B variables. It was founded in 2013 and registered with the SIC code 8733 as Research Institute, and with the NAICS code 541712 as Research Institute.
With a current employee count of 1 to 4, Inno Clinical Outcomes LLC has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Kathryn Bradrick at (919) 274-1901 for related queries, or to locate its Single Location using the coordinates 35.910283,-78.941082.
The Single Location can also be found at the street address 5309 Highgate Drive in Durham, North Carolina 27713 and can be engaged online through the company website at , the company Twitter , and Facebook page .